Record
Loading…
Record
Loading…
organization · fact
As of November 8, 2026, the latest revenue figure on the AsOf record for AbbVie is $17.4 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). AbbVie's latest full-year revenue is $61.16 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared.
| value | valid from | valid to | status | conf | sources | claim |
|---|---|---|---|---|---|---|
| $17.44 billion: revenue 17,444,000,000 United States dollar from 2011-12-31, claim clm_A43C77B35651 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_A43C77B35651 | ||||
| $18.38 billion: revenue 18,380,000,000 United States dollar from 2012-12-31, claim clm_7D34A43B5B1E and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_7D34A43B5B1E | ||||
| $18.79 billion: revenue 18,790,000,000 United States dollar from 2013-12-31, claim clm_10EA1069A66F and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_10EA1069A66F | ||||
| $19.96 billion: revenue 19,960,000,000 United States dollar from 2014-12-31, claim clm_3A0D33F3133A and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_3A0D33F3133A | ||||
| $22.86 billion: revenue 22,859,000,000 United States dollar from 2015-12-31, claim clm_778004ECC385 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_778004ECC385 | ||||
| $25.64 billion: revenue 25,638,000,000 United States dollar from 2016-12-31, claim clm_B8A18C367510 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_B8A18C367510 | ||||
| $28.22 billion: revenue 28,216,000,000 United States dollar from 2017-12-31, claim clm_9C790281A637 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_9C790281A637 | ||||
| $32.75 billion: revenue 32,753,000,000 United States dollar from 2018-12-31, claim clm_67CC49EA52CC and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_67CC49EA52CC | ||||
| $33.27 billion: revenue 33,266,000,000 United States dollar from 2019-12-31, claim clm_EB4D7B27A2A8 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_EB4D7B27A2A8 | ||||
| $45.8 billion: revenue 45,804,000,000 United States dollar from 2020-12-31, claim clm_34A920A5AE6F and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_34A920A5AE6F | ||||
| $56.2 billion: revenue 56,197,000,000 United States dollar from 2021-12-31, claim clm_D102FEEF7A89 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_D102FEEF7A89 | ||||
| $58.05 billion: revenue 58,054,000,000 United States dollar from 2022-12-31, claim clm_C6FBA5E61236 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_C6FBA5E61236 | ||||
| $54.32 billion: revenue 54,318,000,000 United States dollar from 2023-12-31, claim clm_94FBAE0710ED and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_94FBAE0710ED | ||||
| $56.33 billion: revenue 56,334,000,000 United States dollar from 2024-12-31, claim clm_46C087CADCC6 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_46C087CADCC6 | ||||
| $61.16 billion: revenue 61,160,000,000 United States dollar from 2025-12-31, claim clm_4A7BE8ED0078 and its sources | valid: Two independent sources agree, or a primary source states it: the record asserts this claim. | clm_4A7BE8ED0078 |
AsOf. "AbbVie quarterly revenue: 17,404,000,000 United States dollar", as of 2026-09-30. Claim clm_DA52AAE1BFB4, https://asof.is/claim/clm_DA52AAE1BFB4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm.
AsOf. (2026). AbbVie quarterly revenue: 17,404,000,000 United States dollar (as of 2026-09-30) [Record clm_DA52AAE1BFB4]. Retrieved November 8, 2026, from https://asof.is/claim/clm_DA52AAE1BFB4 (source: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm)
@misc{asof_clm_DA52AAE1BFB4,
author = {AsOf},
title = {AbbVie quarterly revenue: 17,404,000,000 United States dollar},
year = {2026},
howpublished = {\url{https://asof.is/claim/clm_DA52AAE1BFB4}},
note = {Claim clm\_DA52AAE1BFB4, as of 2026-09-30; source: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm},
urldate = {2026-11-08}
}